Clinical trial Recruiting at 1 site Interventional Ages 18 and up

CCTA-Guided CABG vs CAG-Guided CABG

Official title: Coronary Computed Tomography Angiography-Based Versus Coronary Angiography-Based Coronary Artery Bypass Grafting: A Multicenter Pragmatic Non-Inferiority Randomized Controlled Trial

Run by Ruijin Hospital · NCT07769008 · Data updated 2026-11-12

This study tests whether planning CABG with a non-invasive CCTA scan works as well as planning with the standard invasive CAG approach for people with blocked heart arteries.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment826 (estimated)
SponsorRuijin Hospital
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedAugust 17, 2026
Main results expectedAugust 2029
Study endsAugust 2029
Registry record updatedOctober 27, 2026
Trial IDNCT07769008 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults referred for CABG who can safely undergo either CCTA or CAG planning and provide informed consent.

Probably not a fit

Patients who cannot undergo CCTA or CAG due to contraindications or who experience outcomes not influenced by planning method may see no difference.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter pragmatic trial compares two ways of planning coronary artery bypass grafting: using coronary computed tomography angiography (CCTA) versus using coronary angiography (CAG). Participants are randomized to have either planning method guide their CABG, and both groups receive CABG per local protocol. The trial looks at 1-year outcomes including heart attacks, strokes, need for additional procedures, and length of hospital stay, with an internal pilot to assess feasibility and protocol adherence. Primary feasibility outcomes cover screening, consent, randomization, recruitment rate, concordance between planned and actual revascularization, and follow-up completion at 7 and 30 days. The study also explores graft-related outcomes and early morbidity and mortality. Lead sponsor is Ruijin Hospital, with the study conducted at Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Why it matters

Potential benefit: If successful, patients and clinicians could have a non-invasive, equally effective way to plan CABG, potentially reducing procedure-related risks and discomfort.

How similar studies have gone: Prior studies in imaging-guided planning have shown promise, but this direct non-inferiority comparison for CABG planning is relatively novel and exploratory in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Referred to CABG treatment

Exclusion Criteria:

* Under the age of 18 years
* Unable to provide informed consent
* Emergency CABG
* Redo-CABG
* Prior PCI with coronary stent implantation and unable to undergo photon counting CCTA.
* Cardiogenic shock
* Unable to undergo CAG or CCTA examination or deemed unsuitable by the investigator, such as:

Known allergy to iodinated contrast media; Active hyperthyroidism or uncontrolled thyroid disease; Estimated glomerular filtration rate (eGFR) \< 30 mL/min/1.73 m²; Atrial fibrillation with rapid ventricular response or severe arrhythmias not amenable to rate control;

* Pregnancy, lactation, or childbearing potential without effective contraception in female participants
* Concurrent participation in another interventional trial

Where it's running

  • Ruijin Hospital Shanghai Jiao Tong University School of Medicine
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.